NCT07456800 PK of Deupirfenidone Versus Pirfenidone in Older Healthy Subjects Status COMPLETED Phase PHASE1
NCT07284602 Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF) Status NOT_YET_RECRUITING Phase PHASE3
NCT06717100 Study to Determine Potential for Drug-drug Interactions When Co-administering Deupirfenidone (LYT-100) and Nintedanib Status COMPLETED Phase PHASE1
NCT05829226 A Phase 1 Study With LYT-200 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML), or With Relapsed/Refractory, High-risk Myelodysplastic Syndrome (MDS) Status COMPLETED Phase PHASE1
NCT05321420 LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04666688 LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1/PHASE2